May 25 (Reuters) - Fisher & Paykel Healthcare Corporation
Ltd FPH.NZ :
* APPROVED AN INCREASED FINAL DIVIDEND OF 22.5 NZ CENTS PER
SHARE
* DIRECTORS ALSO APPROVED A PROFIT-SHARING PAYMENT TOTALLING
NZ$19
MILLION FOR 2022 FINANCIAL YEAR
* FY OPERATING REVENUE 15% DECLINE TO NZ$1.68 BILLION
* FY NET PROFIT AFTER TAX NZ$376.9 MILLION, 28% DECLINE
* EXPECT TO INVEST APPROXIMATELY NZ$700 MILLION IN LAND AND
BUILDINGS OVER APPROXIMATELY FIVE YEARS
* DO NOT EXPECT HOSPITAL HARDWARE REVENUE FOR 2023 FINANCIAL
YEAR
TO CONTINUE AT FY22 LEVELS
* LAUNCHED TWO NEW PRODUCTS DEVELOPED SPECIFICALLY FOR USE
IN
ANESTHESIA APPLICATIONS
* EXPECT TO HOLD HIGHER LEVELS OF INVENTORY TO HELP ADDRESS
GLOBAL
SUPPLY CHAIN CHALLENGES
* NOT CURRENTLY PROVIDING QUANTITATIVE REVENUE OR EARNINGS
GUIDANCE FOR 2023 FY
* HOSPITAL CONSUMABLES SUBSEQUENT TRADING TO DATE IS
EXHIBITING A
SLOW RECOVERY FROM FEBRUARY
* IF FREIGHT RATES REMAIN AT CURRENT LEVELS, EXPECT CONSTANT
CURRENCY GROSS MARGIN IN 2023 FY TO BE IN LINE WITH 2022 FY
* UNVEILS NEW AIRVO 3 HIGH FLOW SYSTEM
Source text for Eikon: ID:
Further company coverage: FPH.NZ